Literature DB >> 21254382

Polysorbate cationic synthetic vesicle for gene delivery.

Yongzhuo Huang1, Yuefeng Rao, Jinliang Chen, Victor C Yang, Wenquan Liang.   

Abstract

Synthetic nonionic surfactant vesicles (niosomes) are a colloidal system with closed bilayer structures, displaying distinct advantages in stability and cost compared with liposomes. In this article, polysorbate cationic niosomes (PCNs) were developed as gene carriers. The PCNs comprised nonionic surfactants (i.e., polysorbates) and a cationic cholesterol, and were synthesized using a film hydration method. The niosomes thus prepared possessed a regular morphology, and a particle size of 100 ∼ 200 nm, and a zeta potential of +30 ∼ 45 mV. The PCNs showed great physical stability over the course of 4 weeks at room temperature. The binding capacity of PCNs toward oligodeoxynucleotides (ODN) was assessed by a gel retardation approach, which demonstrated that the ionic complexes were formed when ± charge ratio reached to 4 or greater. Gene transfer study showed that the PCNs exhibited a high efficiency in mediating cellular uptake and transferred DNA expression. Based on these findings, PCNs may offer the potential to function as an effective gene delivery system.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254382      PMCID: PMC3065677          DOI: 10.1002/jbm.a.32999

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  26 in total

1.  Physicochemical characterization of influenza viral vaccine loaded surfactant vesicles.

Authors:  S C Chattaraj; S K Das
Journal:  Drug Deliv       Date:  2003 Apr-Jun       Impact factor: 6.419

2.  Gene transfection into HeLa cells by vesicles containing cationic peptide lipid.

Authors:  Yumi Ohama; Yuji Heike; Takuya Sugahara; Kozue Sakata; Norikazu Yoshimura; Yoshio Hisaeda; Mami Hosokawa; Shigemitsu Takashima; Keiichi Kato
Journal:  Biosci Biotechnol Biochem       Date:  2005-08       Impact factor: 2.043

3.  Cationic niosomes as gene carriers: preparation and cellular uptake in vitro.

Authors:  Y Z Huang; G Han; H Wang; W Q Liang
Journal:  Pharmazie       Date:  2005-06       Impact factor: 1.267

4.  Cationic liposomes modified with non-ionic surfactants as effective non-viral carrier for gene transfer.

Authors:  Yong-Zhuo Huang; Jian-Qing Gao; Jin-Liang Chen; Wen-Quan Liang
Journal:  Colloids Surf B Biointerfaces       Date:  2006-03-22       Impact factor: 5.268

5.  Contribution of hydrophobicity of nonionic detergents to membrane lipid fluidity and disopyramide uptake by rat intestinal brush-border membrane vesicles.

Authors:  K Koga; M Murakami; S Kawashima
Journal:  Biol Pharm Bull       Date:  1997-06       Impact factor: 2.233

6.  A novel cationic liposome reagent for efficient transfection of mammalian cells.

Authors:  X Gao; L Huang
Journal:  Biochem Biophys Res Commun       Date:  1991-08-30       Impact factor: 3.575

7.  Low toxicity of cationic lipid-based emulsion for gene transfer.

Authors:  Woo-Jeong Choi; Jin-Ki Kim; Sung-Hee Choi; Jeong-Sook Park; Woong Shick Ahn; Chong-Kook Kim
Journal:  Biomaterials       Date:  2004-12       Impact factor: 12.479

8.  Delivery of interleukin-18 gene to lung cancer cells using cationic emulsion.

Authors:  Hyun-Suk Kang; Shun-Ji Jin; Chang-Seon Myung; Sung-Joo Hwang; Jeong-Sook Park
Journal:  J Drug Target       Date:  2009-01       Impact factor: 5.121

9.  PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides.

Authors:  Yongzhuo Huang; Jinliang Chen; Xiaojin Chen; Jianqing Gao; Wenquan Liang
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

10.  Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer.

Authors:  Donatella Paolino; Donato Cosco; Rita Muzzalupo; Elena Trapasso; Nevio Picci; Massimo Fresta
Journal:  Int J Pharm       Date:  2007-11-28       Impact factor: 5.875

View more
  7 in total

Review 1.  Current status of non-viral gene therapy for CNS disorders.

Authors:  Rahul Dev Jayant; Daniela Sosa; Ajeet Kaushik; Venkata Atluri; Arti Vashist; Asahi Tomitaka; Madhavan Nair
Journal:  Expert Opin Drug Deliv       Date:  2016-06-01       Impact factor: 6.648

2.  Nonionic surfactant vesicles composed of novel spermine-derivative cationic lipids as an effective gene carrier in vitro.

Authors:  Orapan Paecharoenchai; Nattisa Niyomtham; Lalita Leksantikul; Tanasait Ngawhirunpat; Theerasak Rojanarata; Boon-ek Yingyongnarongkul; Praneet Opanasopit
Journal:  AAPS PharmSciTech       Date:  2014-03-13       Impact factor: 3.246

3.  Nonionic surfactant vesicles for delivery of RNAi therapeutics.

Authors:  Orapan Paecharoenchai; Lesheng Teng; Bryant C Yung; Lirong Teng; Praneet Opanasopit; Robert J Lee
Journal:  Nanomedicine (Lond)       Date:  2013-11       Impact factor: 5.307

4.  Saponins enhance exon skipping of 2'-O-methyl phosphorothioate oligonucleotide in vitro and in vivo.

Authors:  Mingxing Wang; Bo Wu; Sapana N Shah; Peijuan Lu; Qilong Lu
Journal:  Drug Des Devel Ther       Date:  2018-10-31       Impact factor: 4.162

5.  The Synergism of Platinum-Gold Bimetallic Nanoconjugates Enhances 5-Fluorouracil Delivery In Vitro.

Authors:  Vareessh Maney; Moganavelli Singh
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321

6.  The Importance of Poly(ethylene glycol) and Lipid Structure in Targeted Gene Delivery to Lymph Nodes by Lipid Nanoparticles.

Authors:  Danijela Zukancic; Estelle J A Suys; Emily H Pilkington; Azizah Algarni; Hareth Al-Wassiti; Nghia P Truong
Journal:  Pharmaceutics       Date:  2020-11-09       Impact factor: 6.321

7.  Poly(ester amine) Composed of Polyethylenimine and Pluronic Enhance Delivery of Antisense Oligonucleotides In Vitro and in Dystrophic mdx Mice.

Authors:  Mingxing Wang; Bo Wu; Jason D Tucker; Lauren E Bollinger; Peijuan Lu; Qilong Lu
Journal:  Mol Ther Nucleic Acids       Date:  2016-08-02       Impact factor: 10.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.